Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Williams

Showing results (311-320 of 417) with videos related to

Pageof 42
Sort By:
The Lancet. Neurology|March 19, 2022
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programmeSimon Mead, Azadeh Khalili-Shirazi, Caroline Potter, et al.
Journal of Critical Care|September 19, 2021
Influence of IL-6 levels on patient survival in COVID-19Nishkantha Arulkumaran, Timothy A C Snow, Adarsh Kulkarni, et al.
Lancet (London, England)|October 14, 2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trialIsla S Mackenzie, Amy Rogers, Neil R Poulter, et al.
Lancet (London, England)|October 9, 2022
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessedMary Y Wu, Edward J Carr, Ruth Harvey, et al.
Journal of the American Society of Nephrology : JASN|February 20, 2009
Lowering blood pressure reduces renal events in type 2 diabetesBastiaan E de Galan, Vlado Perkovic, Toshiharu Ninomiya, et al.
BMJ (Clinical Research Ed.)|January 20, 2021
Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trialRichard J McManus, Paul Little, Beth Stuart, et al.
JAMA|May 14, 2025
Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical TrialChan Joo Lee, Sang-Hyun Ihm, Dong-Ho Shin, et al.
BMC Medicine|February 12, 2025
Healthy lifestyle factors and combined macrovascular and microvascular events in diabetes patients with high cardiovascular risk: results from ADVANCEShoujiang You, Danni Zheng, Yanan Wang, et al.
Vaccine|March 8, 2025
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeuticsGiulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Hypertension (Dallas, Tex. : 1979)|May 29, 2019
Frequency and Prognosis of Treated Hypertensive Patients According to Prior and New Blood Pressure GoalsLuis M Ruilope, Gema Ruiz-Hurtado, María G Barderas, et al.
Pageof 42

Showing results (311-320 of 417) with videos related to

Sort By:
Pageof 42
The Lancet. Neurology|March 19, 2022
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programmeSimon Mead, Azadeh Khalili-Shirazi, Caroline Potter, et al.
Journal of Critical Care|September 19, 2021
Influence of IL-6 levels on patient survival in COVID-19Nishkantha Arulkumaran, Timothy A C Snow, Adarsh Kulkarni, et al.
Lancet (London, England)|October 14, 2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trialIsla S Mackenzie, Amy Rogers, Neil R Poulter, et al.
Lancet (London, England)|October 9, 2022
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessedMary Y Wu, Edward J Carr, Ruth Harvey, et al.
Journal of the American Society of Nephrology : JASN|February 20, 2009
Lowering blood pressure reduces renal events in type 2 diabetesBastiaan E de Galan, Vlado Perkovic, Toshiharu Ninomiya, et al.
BMJ (Clinical Research Ed.)|January 20, 2021
Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trialRichard J McManus, Paul Little, Beth Stuart, et al.
JAMA|May 14, 2025
Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical TrialChan Joo Lee, Sang-Hyun Ihm, Dong-Ho Shin, et al.
BMC Medicine|February 12, 2025
Healthy lifestyle factors and combined macrovascular and microvascular events in diabetes patients with high cardiovascular risk: results from ADVANCEShoujiang You, Danni Zheng, Yanan Wang, et al.
Vaccine|March 8, 2025
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeuticsGiulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Hypertension (Dallas, Tex. : 1979)|May 29, 2019
Frequency and Prognosis of Treated Hypertensive Patients According to Prior and New Blood Pressure GoalsLuis M Ruilope, Gema Ruiz-Hurtado, María G Barderas, et al.
Pageof 42